Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
TechMediaBreaks – Bebuzee Inc.’s (BBUZ) Revolutionary Platform Poised to Redefine Digital Landscape Across Western Markets
Company: Bebuzee Inc. (BBUZ)
Category: Stock Spotlights
May 10, 2024
Bebuzee (OTC: BBUZ) recently announced the development of its revolutionary super app, set to redefine social engagement and streaming services across Western markets. “With a focus on innovation and user-centric design, Bebuzee introduces an all-encompassing platform that combines the best of social networking, streaming and informational resources seamlessly integrated into one dynamic interface. The Bebuzee Super app is engineered to cater to its members’ diverse interests and needs, offering a myriad of features designed to enhance their digital experiences. From video streaming to photo sharing, from messaging services to real estate searches, Bebuzee is a one-stop destination for entertainment, communication and information consumption. With a user-friendly interface and cutting-edge technology, Bebuzee empowers users to access a wide variety of content on any internet-connected device, making it the ultimate companion for the modern digital lifestyle,” a recent article reads. “Bebuzee’s dedication to delivering relevant, localized content sets it apart in an increasingly crowded digital landscape… While still developing, the super app promises a growing revolution in how users access and interact with content, offering a seamless experience across any internet-connected device… With its imminent transition to a more polished version in the coming months, Bebuzee aims to redefine the digital landscape by offering users unparalleled convenience and access to diverse content.”
To view the full article, visit https://ibn.fm/5EMBm
About Bebuzee Inc.
Bebuzee, headquartered in Miami, Florida, is at the vanguard of developing America’s first Super App, Bebuzee. With a vision to redefine how we connect, engage and thrive in the digital era, Bebuzee is committed to delivering trusted and resilient digital solutions across a myriad of platforms. For further details, please visit www.Bebuzee.com.
NOTE TO INVESTORS: The latest news and updates relating to BBUZ are available in the company’s newsroom at https://ibn.fm/BBUZ
Thanks Rig…to you as well…🥳
Same to you and all buddy.
Get some rest and enjoy a good meal or 5
I know I will.
NSAV....0098...Beauty Close here...🥳Break/Hold .0104 on Monday and we see .014 plus...imo...we shall see...
georgie18
Member Level
Re: None
Friday, May 10, 2024 2:31:57 PM
Post#
216475
of 216513
NSAV...0081s starting here...🥳...Gotta get through .0088 range and we see .01... https://schrts.co/rAGHFNhM ...
NSAV...0081s starting here...🥳...Gotta get through .0088 range and we see .01... https://schrts.co/rAGHFNhM ...
NSAV...008s getting tapped on the 4 mill ask block...🥳
PRST...1661... https://schrts.co/gQwkQbDx ...Bands Choking the PPS...🥳
SGMO...5605...Trying for Upper Bollie Breakout here...🥳
georgie18
Member Level
Re: None
Thursday, May 09, 2024 8:50:47 AM
Post#
380528
of 380553
SGMO...49...NEWS...🥳...May 09, 2024 08:05 AM Eastern Daylight Time
RICHMOND, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today presented pre-clinical data showcasing its novel next-generation integrase technology engineered to enable large-scale genome editing. Building on Sangamo’s deep expertise in protein-DNA interactions derived from its zinc finger platform, the Modular Integrase (MINT) platform is a versatile, protein-guided genome editing method designed to integrate large sequences of DNA into the genome to potentially treat – with a single medicine – patients who have unique mutations in the same gene.
“Precisely integrating large DNA constructs into desirable chromosomal sites has traditionally been challenging for the field. We are excited that our new MINT platform potentially addresses this long-standing problem and would allow us to pursue new indications by inserting or replacing entire genes,” said Greg Davis, Ph.D., Head of Technology at Sangamo. “Using compact, protein-guided integrases built from Bxb1 variants as a means of targeted integration expands our genome editing abilities and capitalizes on the strength of Sangamo’s structural protein-DNA engineering capabilities to deliver potential genomic medicines to the patients who need them most.”
The MINT platform utilizes Bxb1, a serine recombinase, to integrate large sequences of DNA into the genome and is intended to avoid double stranded DNA breaks as well as the need for assistance from ancillary genome editing or DNA-repair modulating cargo. This flexible approach is cell-type agnostic, has been engineered to be simpler to manufacture than most other targeted integration technologies and is compatible with adeno-associated virus (AAV), lentiviral and lipid nanoparticle (LNP) delivery. With minimal dependence on cell DNA repair machinery, we believe the MINT platform carries a reduced translocation risk and our pre-clinical data have demonstrated high levels of on-target integration in certain locations.
Based on these initial findings, we believe the MINT platform could be deployed internally for neurology-focused indications, and could provide potential new collaboration opportunities, both for human disease and in agricultural biotech settings.
NSAV...0079...Hit .0085...HOD...Looking for .01 Break again...🥳
TKMO...0006...Went Pink Current Today...now can we get some volume please...🥳
georgie18
Member Level
Re: None
Wednesday, May 08, 2024 1:46:41 PM
Post#
380522
of 380551
TKMO...0006 off the .0004 dip...62 Million Volume...https://www.sec.gov/Archives/edgar/data/1946585/000121390024040692/ea0205547-1aw_tekumo.htm
AZTR swept out the weak on good report, they in bed with Bayer:
https://www.fiercebiotech.com/biotech/bayer-partnered-azitra-hopes-apply-75m-ipo-proceeds-near-clinical-dermatology-pipeline
This hit $2.39 Wednesday from my low alert on this News...
CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck Cancer
I guess shorts hit it maybe counting on a financing like we see so often after news.
But now, the insiders are buying open market stock which means there isnt any financing right now imo.
https://finance.yahoo.com/news/cel-sci-receives-fda-ahead-130000511.html
$1.64 ^ traction and another form 4...
$CVM $1.60...
— Rigatoni (@rigatoni33) May 10, 2024
Another solid insider buy,
On May 8, 2024, Mr. Watson purchased 20,000 shares of restricted stock directly from the Company at the closing price on May 8, 2024, the most recent closing price availablehttps://t.co/6kv6NcxFiZ https://t.co/i49hpegLPu
HOLO 1.76 loaded
This post is excellent and spot on...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174390429
let's see how it goes, been quiet a long time. Notes om there so that's what OTCN likely is. But, its moving ~Rig
they merged. 1-6 split upcoming. should be stronger entity afterwards. no position, just mentioning recent events.
Some preliminary research indicates something scammy......OTCM data is WAY out of date..........SEC Filings:
https://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=BLIS&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany
Z
$BLIS had a 21 Fact on #DDAmanda yesterday....Traded $130K..........fwiw
Z
And this tweet I just noticed from the CEO...
$CVM Thank you for the go-ahead from FDA for the confirmatory trial. We already know how the selected patients did in the completed study. 73% survival with Multikine vs 45% without Multikine. We can help a lot of patients. I believe! So I bought more stock.
— Geert Kersten (@GeertKersten1) May 9, 2024
A few form 4s today for...
CVM 1.50..
CEO...
On May 8, 2024, Mr. Kersten purchased 30,000 shares of restricted stock directly from the Company at the closing price on May 8, 2024, the most recent closing price available.
http://archive.fast-edgar.com/20240509/APV2E22CW222D232222I22Z2CGBUZ2224262/
http://archive.fast-edgar.com/20240509/APVCK22CW222P232222G22Z2BVFPZ2224262/
Bebuzee Inc. (BBUZ) Readies for the Official Launch of Bebuzee, the First Super App in America and Europe
May 9, 2024
Bebuzee is preparing for the official launch of its Super App, which is poised to be the first Super App in America and Europe
The official launch follows a beta testing phase that began last July
The company believes the Super App will revolutionize the digital world by offering an all-in-one, seamless platform designed to integrate a continuously expanding roster of services
The Super App brings together content streaming, social media, messaging, e-commerce, real estate exploration tools, a digital asset trading platform, productivity tools, and so much more
Last summer, Bebuzee (OTC: BBUZ), a company looking to redefine how people connect, engage, and thrive in the digital era, launched in beta its flagship product, a Super App that offers users a centralized hub for all their communication and entertainment needs. In the press release announcing the beta launch (https://ibn.fm/o5kfc), the company termed the Super App a “symbol of our commitment to innovation and excellence,” further noting that the groundbreaking technologies packaged into its Super App would “revolutionize the industry and set a new standard for digital platforms.”
The launch was an extension of efforts to solve a gap in the market: Bebuzee had observed consumers’ frustrations of constantly needing to switch between applications when hunting for information. To the company, this represented an opportunity to provide various apps and functionalities on an all-in-one platform. And the company is closing in on making this a reality with the beta phase now drawing to an imminent end.
Recently, Bebuzee announced that it is preparing for the official launch of the Super App. The Super App is set to offer an all-in-one, seamless platform that integrates multiple services, thus revolutionizing the digital world. The platform is poised to be the first Super App in America and Europe and represents a new dawn for digital integration, according to the company (https://ibn.fm/DvRAa).
The Bebuzee Super App integrates content streaming, social media, messaging, e-commerce, real estate exploration tools, a digital asset trading platform, productivity tools, and more. What’s more, according to the company, the Super App, is differentiated as the only “social media platform to localize its content for specific countries and also the only streaming service to offer movies, documentaries, series talk shows, and more at no cost to the viewer.” As a result of these unique capabilities and offerings, the company says, the Bebuzee Super App has essentially “no competition.”
To put its differentiated capabilities into perspective, the Super App’s core features include video streaming; messaging; photo sharing; Shortbuz, a tool that enables users to make short-form entertaining videos; Properbuz, a global real estate search tool; TravelBuz, an online travel agency for lodging reservations and other travel products; EventBuz, a ticket exchange and resale service; FlightBuz, a flights-search engine and travel agency; Bebuzee Pay, a mobile payment and digital wallet service; location reviews; Blogbuz, a service that scans the world’s news, features, and information flow and displays it to readers, offering them the best of the internet in one place; and ShoppingBuz, an e-commerce service (https://ibn.fm/iq04r).
By merging these cutting-edge capabilities and features into an all-in-one solution, the Super App provides users with a seamless, simplified, enriched, and immersive digital experience that is further complemented by a user-friendly interface. The company believes that these and other features and capabilities will ultimately make the Super App indispensable to users’ daily lives.
“The Bebuzee Super App is not just an app; it’s a revolution. We’re about to change the game by offering a comprehensive digital ecosystem that caters to every user’s needs, all within a single platform. This is more than an app; it’s a new way of life for social media users globally. We can’t wait for everyone to experience the future of digital engagement,” said Joe Onyero, CEO of Bebuzee, in the press release announcing plans for the official launch.
The official launch of the Super App is set to position Bebuzee at the forefront of a growing super apps market, which is expected to reach $722.4 billion by 2023 from $58.6 billion in 2022, growing at a 28.9% CAGR, according to analysts at Allied Market Research (https://ibn.fm/bU0Oa). And with a 2022 survey showing that Australia, Germany, the United Kingdom, and the United States are among the leading global markets for super apps (https://ibn.fm/euBuj), Bebuzee has taken a strategic approach with its initial plans to introduce its Super App in Europe and America.
For more information, visit the company’s website at www.Bebuzee.com.
NOTE TO INVESTORS: The latest news and updates relating to BBUZ are available in the company’s newsroom at https://ibn.fm/BBUZ
About TechMediaWire
TechMediaWire (“TMW”) is a specialized communications platform with a focus on pioneering public and private companies driving the future of technology. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, TMW brings its clients unparalleled recognition and brand awareness. TMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.TechMediaWire.com
Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer
TechMediaWire
Los Angeles, CA
www.TechMediaWire.com
310.299.1717 Office
Editor@TechMediaWire.com
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174386680
$3.75 pretty strong off that interview yesterday ~Rig
This one getting some volume...
BLIS .04
Now this is legitimacy...
Low life scumbag bashers will likely come up with some photo shop conspiracy... lmao
https://twitter.com/SpoozInc/status/1788570163014484130
https://twitter.com/SpoozInc/status/1788570163014484130
May get the pop on this news...
ALLR .79
http://archive.fast-edgar.com/20240509/AJ22C22CLZ228282229J22Y2BUBDM222E262/ea0205578ex99-1_allarity.htm
TAOP.......................MULN......................................https://stockcharts.com/h-sc/ui?s=MULN&p=W&yr=1&mn=3&dy=0&id=p96837884856
https://stockcharts.com/h-sc/ui?s=TAOP&p=W&yr=1&mn=3&dy=0&id=p96837884856
From 4 just hit, a great sign...
$CVM $1.50...
— Rigatoni (@rigatoni33) May 9, 2024
Hit $2.39 yesterday, retrace and all set to move back up with this hitting imo
Nice form 4 filed ...https://t.co/HSKPlxNIww
Common Stock05/08/2024
P 30,000 (1)A$ 1.391,195,309 pic.twitter.com/VF3yl7lWyy
Looks to be a great pickin area imo...
$VIRI .43...
— Rigatoni (@rigatoni33) May 9, 2024
Looks like a nice place to grab imo,
News...
Key Highlights
•The BHC-202 3-arm study comparing two dose levels of the valacyclovir/celecoxib combination vs placebo over 12 weeks to treat symptoms of LC is being conducted by the Bateman Horne Center (“BHC”)… pic.twitter.com/6WnrRKP6bi
SGMO...49...NEWS...🥳...May 09, 2024 08:05 AM Eastern Daylight Time
RICHMOND, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today presented pre-clinical data showcasing its novel next-generation integrase technology engineered to enable large-scale genome editing. Building on Sangamo’s deep expertise in protein-DNA interactions derived from its zinc finger platform, the Modular Integrase (MINT) platform is a versatile, protein-guided genome editing method designed to integrate large sequences of DNA into the genome to potentially treat – with a single medicine – patients who have unique mutations in the same gene.
“Precisely integrating large DNA constructs into desirable chromosomal sites has traditionally been challenging for the field. We are excited that our new MINT platform potentially addresses this long-standing problem and would allow us to pursue new indications by inserting or replacing entire genes,” said Greg Davis, Ph.D., Head of Technology at Sangamo. “Using compact, protein-guided integrases built from Bxb1 variants as a means of targeted integration expands our genome editing abilities and capitalizes on the strength of Sangamo’s structural protein-DNA engineering capabilities to deliver potential genomic medicines to the patients who need them most.”
The MINT platform utilizes Bxb1, a serine recombinase, to integrate large sequences of DNA into the genome and is intended to avoid double stranded DNA breaks as well as the need for assistance from ancillary genome editing or DNA-repair modulating cargo. This flexible approach is cell-type agnostic, has been engineered to be simpler to manufacture than most other targeted integration technologies and is compatible with adeno-associated virus (AAV), lentiviral and lipid nanoparticle (LNP) delivery. With minimal dependence on cell DNA repair machinery, we believe the MINT platform carries a reduced translocation risk and our pre-clinical data have demonstrated high levels of on-target integration in certain locations.
Based on these initial findings, we believe the MINT platform could be deployed internally for neurology-focused indications, and could provide potential new collaboration opportunities, both for human disease and in agricultural biotech settings.
$3.58...
Some good exposure
Tune in CNN International today at 6:40pm ET/ 3:40pm PT to see Triller CEO @BobbySarnevesht Live on First Move with Julia Chatterley ‼️
— TRILLER (@triller) May 8, 2024
.
.#CNN #CNNInternational #FirstMove #TuneIn #Triller #Trending pic.twitter.com/9bARW52Zfd
I found this on SMCE after market close today
$SMCE Portfolio Bank stocks include VEEV $201.77 GOOGL $171.16 JD $31.95 BABA $78.46 IMMR $7.51 NVDA $904.12 EA $125.24 META $472.60 ADBE $488.10 QCOM $ 180.55 AAPL $182.74 MSFT $ $410.54 BIDU $109.60
— Brian Sowa (@sowa32214) May 8, 2024
AI Fintechhttps://t.co/uMe4wrgZAz
NSAV...0072s up again...Big Block .0069 cleared here...🥳Ask thinned out...
NSAV...0068...on the dip...1million share on top ask getting tapped here...🥳
TKMO...0006 off the .0004 dip...62 Million Volume...https://www.sec.gov/Archives/edgar/data/1946585/000121390024040692/ea0205547-1aw_tekumo.htm
Nice dd here...
Korean Kogas is a $36B+ Company as of 2022 with 4000 employeeshttps://t.co/jhZ5nEoNPl$SPZI board member is former Executive President of KOGAS "KiSoo Kim"
— Rise2ShineLife (@Rise2ShineLife) May 8, 2024
Keep waiting on filings, It's coming.https://t.co/X43QfgpBRS https://t.co/KcxlQ3fPTP pic.twitter.com/p5gPX9jISK
TIVC...$1.17...was over $2 in the P/M...Perhaps it will fill that open gap...🥳...
georgie18
Member Level
Re: georgie18 post# 642560
Wednesday, May 08, 2024 9:22:05 AM
Post#
642566
of 642629
TIVC...$1.60 on the dip...Will hedge with bids at the gap...🥳
SMCE current pink just started moving now.
I have been buying over the last couple weeks but I don’t know what is going on today
MI...$8.93...Off my $6.57 Alert...🥳
georgie18
Member Level
Re: georgie18 post# 642147
Tuesday, May 07, 2024 9:56:01 AM
Post#
642381
of 642624
MI...$7.80...Off my $6.57Alert...🥳...Hit $11.55 High yesterday...
georgie18
Member Level
Re: None
Friday, May 03, 2024 11:21:01 AM
Post#
642147
of 642379
MI...$6.57...Heavy Volume...on a Low Floater...I have no position at the moment...🥳
$EBYH is very undervalued and the float and outstanding and very conservative. This stock is the best long term play in the cannabis data and technology part of the industry. With the high probability that Schedule 1 goes to schedule 3 in 2024, Strainsforpains’ services and products will be in great demand.
Here is promo video, CEO audio, as well as video interview.
NNVC......NIVF.......TIVC........MULN.................https://stockcharts.com/h-sc/ui?s=MULN&p=W&yr=1&mn=3&dy=0&id=p96837884856
https://stockcharts.com/h-sc/ui?s=TIVC&p=W&yr=1&mn=3&dy=0&id=p96837884856
https://stockcharts.com/h-sc/ui?s=NIVF&p=W&yr=1&mn=3&dy=0&id=p96837884856
https://stockcharts.com/h-sc/ui?s=NNVC&p=W&yr=1&mn=3&dy=0&id=p96837884856
$2.39 ~Rig
Welcome to " Platinum Penny Alerts "
Objective...
This site is for investors/traders who wish to share ideas and opinions about penny stocks in a responsible manner. The focus will be diversified to include; day trading, swing trading, bottom reversals, mid-term and long-term growth investing with emphasis on finding the next Platinum Penny Alerts, before the masses uncover it. Discovering one of these nuggets and accumulating a large position can be greatly rewarding while the story unfolds; holding a core position long while also maintaining some trading shares can be good strategy. One big winner every one to two years will make you more money than flipping a large number of stocks during the same time frame. There is a season for every investing style, whether it's day trading, momentum plays, chart plays or others. I personally am open to all styles of trading, but my focus for the bigger profits are mid to longer term plays qualified by thorough due diligence, growth and earnings potential, favorable share structure, minimal downside risk and an attractive chart.
Those of you who have known me a long time, realize the importance I place in picking a stock to invest in. Capital preservation and limiting downside risk are primary. Of course, there are other variables and forces to contend with , many which are out of our control, specifically dilution, credibility and the human factor as it relates to investor relations firms, ceo's and directors of companies who are just hyping their stock and may give out misleading information. Deciphering who is credible in most cases will be revealed in your due diligence process via phone calls, research and through reading the public filings of companies. Additionally, I have also relied on my instincts.
Board criteria for stocks…
For any of your ideas, please support them with some due diligence, which includes company web site links, articles, charts, press releases or whatever is appropriate for that particular pick. Please include the stock symbol at the beginning of your post. Price range is from .01 to 50.00.Sub penny plays are also welcome, but not the primary focus of this board.
~Platinum Focus Penny Picks Ideas
These are stocks we are Looking at for mid to longer term rewards.
I consider these type stocks to meet several possible criteria including: Growth/earnings potential, favorable share structure, attractive chart, relatively undiscovered, strong due diligence and minimal downside risk.
Holding a core position long while also maintaining some trading shares can be good strategy imo.
Quality Creates It's Own Demand
Some Board Guidelines...
Leave your EGO at the door.
No personal attacks.
Off topic posts-use an OT:
No Vulgarity.
No Posting Misinformation.
No redundent posting of promotional plays
No posting in Caps,Italics or Bold
No politics unless it's market related
Respect each other.
No undermining or disruptive posts.
NO SPAM OR LINKING YOUR OWN BOARD FOR DUE DILIGENCE.
Some Due Diligence tools...
GOLD Pricing live chart
http://www.livecharts.co.uk/MarketCharts/gold.php
Corporate Records Search
http://www.coordinatedlegal.com/SecretaryOfState.html'
http://www.searchsystems.net/list.php?nid=398'
*A well rounded learning site for misc questions and guidance about the market...
http://www.investopedia.com/articles/stocks/'
~All encompassing, best tools I have seen anywhere..
http://equityfeed.com/ which is now https://scanz.com/
~SEC Filings
http://www.otcb.com/index.jsp'
http://www.edgar-online.com/'
http://www.nasdaq.com/'
http://knobias.tenkwizard.com/main.php'
~Otcbb lists for symbol changes,s/8's,market stats ...
http://www.otcmarkets.com/'
~Charting...
https://www.stockscores.com/
http://stockcharts.com/index.html'
http://bigcharts.marketwatch.com/'
http://chartpatterns.com/'
~News related searches...
http://finance.yahoo.com/'
http://www.businesswire.com/'
http://www.allstocks.com/homepages/homepage6.htm'
http://www.findarticles.com/'
~Stock Scans...
https://scanz.com/
~Shell stocks link...
What is a shell stock?
http://www.shellstockreview.com/ssr-Home.html
~Exchange Listing requirements...
http://www.venturelawcorp.com/listing_requirements_amex.html'
http://www.investopedia.com/ask/answers/121.asp'
http://www.nasdaq.com/about/listing_information.stm'
http://www.nasdaq.com/about/nasdaq_listing_req_fees.pdf'
http://amex.com/'
~Form definitions...
http://www.gsionline.com/support/formtypes.html'
http://pro.edgar-online.com/help/formdef.asp'
Use all of these links as a guideline. Ultimately, your due diligence will lead you to your own buying/selling decisions. No one on this board is responsible for your financial stability or lack of it.
"Risk comes from not knowing what you're doing." Warren Buffett
Sign up for the boards e mail list by clicking the option "sign up for Rigs Platinum Penny Picks" E Mail List directly below the I Box. I realize not everyone can watch the board during trading hours, making this a good alternative for alerts on potential movers.
Lets make some money!
~Rig
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |